The Thyroid Clearance Rate of Plasma Iodine as a Measure of Thyroid Activity By N. B. MYANT, B.M., and E. E. POCHIN, M.D., F.R.C.P.1 IN the following account of the uptake of radio-iodine by the human thyroid, we wish to describe certain quantitative measures of the rate of uptake, and to discuss their clinical application. Doses of 30 microcuries of f131 have been used, either with no carrier or with 20-microgram amounts of inert iodine. Such doses have been given as iodide either orally or intravenously to normal and thyrotoxic subjects. We have followed the urinary excretion and plasma concentration by conventional liquid counting methods, and have differentiated labelled iodide from thyroxine in the plasma by Taurog and Chaikoff's butanol extraction against alkali. The thyroid uptake of the dose has been determined using a gamma counter opposite the neck with accurate positioning of neck and counter, radiation from the rest of the body being screened by a lead shield [1] . In calculating the radio-iodine content of the gland from the counting rate opposite to it, it is necessary to know both the position of the thyroid and the contribution that scattered radiations make to the count. The former can be quite accurately estimated by making counts with the counter at different distances from the neck, since the counting rate falls off inversely with the square of the separation between counter and source, and thereby reveals the position of the source [2] . The effect of scattered radiations has been determined in separate experiments in which a known dose has been introduced into the neck at the thyroid level in a swallowed Ryle's tube. The observed counting rate from the swallowed tube is compared with that from the same tube hung in air at an equal distance from the counter, and radiations scattered from neck tissues are thereby found to increase the count by about 27 %. In this way, one 'can determine the percentage ofa dose in the thyroid and in the urine, and its concentration in plasma at, any interval after its administration. Fig. 1 shows that, as an average of a group of normal subjects, the thyroid continues to take up iodine for two Work undertaken on behalf of the Medical Research Council.
DEC.-ENDOCRIN. 2 or three days, reaches a peak content of about 33 % of the dose, when its content starts to fall slowly. In a group of untreated thyrotoxic subjects, the maximum uptake was greater, was reached earlier, and the iodine was lost more rapidly in the ensuing days. In each group, the urinary changes correspond, an initial stage of rapid excretion being complete in about two days in normal subjects when 60% of the dose has been excreted, excretion continuing at a slow rate thereafter. In thyrotoxics, the initial stage is complete earlier, accounts for a much smaller percentage of the dose, and is followed by a rather faster rate of subsequent excretion. The plasma concentration of radio-iodine ( normal subjects it falls to a low value in two days, during which time the butanol fractionation shows the activity to be due to iodide. The concentration then rises again slowly, and the activity is now found in the thyroxine fraction, where it has been detected at two days, but not earlier, after the dose. In thyrotoxic patients, the iodide fall is more rapid, and the thyroxine rise earlier and greater, and radio-thyroxine has been demonstrated in the plasma as early as three hours after the dose, and is commonly present by seven hours. The following notes deal only with the uptake phase during the first hours after the dose, and before output of radio-thyroxine from the thyroid has appreciably started. It will be noted that in the thyrotoxic as well as in the normal group, equal times are required for completion of thyroid uptake, of the initial urinary excretion and of the removal of radio-iodide from the plasma. Moreover, when the curves are compared in individual subjects, it is found that the rate of rise of the thyroid count is directly proportional to the plasma radio-iodide concentrations at the time. And similarly, the rate of urinary excretion runs proportional to the plasma concentration [1] . This is perhaps an expected result since the body does not distinguish radio-iodine from normal iodine, and the thyroid and kidneys proceed to remove iodide from the plasma at a steady rate regardless of the administration of a test dose of radio-iodide. One may say then that the thyroid is clearing a constant volume of plasma each minute of its contained iodide, and the test dose merely enables us to determine what volume of plasma is so cleared. If, for example, the thyroid is taking up radio-iodine at a rate of 5 % of the dose per hour at a time when the plasma contains 5 %h of the dose per litre, it may be said that the thyroid is clearing 1 litre of plasma per hour of its iodide. As with the conventional renal clearance, this gives a valuable index of the thyroid activity. The renal clearance rate for iodide is determined similarly by the ratio between the rate of urinary excretion of radio-iodide and its plasma concentration at the time.
In practice the determination of clearance rates requires certain precautions. If the determination is made too early after an oral dose, the rise in counting rate opposite the neck is due partly to a rising iodide content of neck muscles. After an hour, however, this content is about constant, as judged from parallel counts over the thigh, and so does not contribute to the speed of rise of the neck counting rate. Again, if the clearance is determined so late that appreciable labelled thyroxine is being discharged from the gland, the plasma radioactivity does not measure only radio-iodide, and the rise of neck count does not measure uptake only, so that low values of the clearance are obtained. The test is still in this sense 960 In0f experimental, and we prefer to base a value on several plasma samples. Valid readings are, however, obtained between one and two hours after an oral dose given several hours after food. And if an intravenous dose is used, the patient can come up as an outpatient at any convenient time and the test be completed with little more than an hour's work.
In subjects without thyroid disease, thyroid clearance rates have lain between 5 and 40 ml. of plasma cleared of their iodide per minute, averaging 25 ml./min. In 15 subjects with clear thyrotoxicosis, values have always exceeded 100 ml./min. and usually exceed 150. The clearance in myxcedema has been a few ml./min. only, and its value in non-toxic goitre has been normal or a little raised, one value of 60 having been observed. The renal clearance for iodide has averaged 30 ml./min., and is unchanged in thyrotoxicosis.
Since at all times the thyroid and kidneys are taking up iodide in proportion to their clearance rates, the amounts in thyroid and urine at the end of the uptake phase should approximately measure the ratio of these rates. After twenty-four hours, most of the dose is in fact shared between thyroid and urine in about this ratio, the amount in the tissues being under 10% except in cases of thyrotoxicosis with rapid output from the thyroid. The urinary excretion by twenty-four hours is then a rough measure of the ratio between renal clearance and the combined renal and thyroid clearance. It affords therefore an easily determined index which is influenced by the thyroid clearance. Unfortunately, the renal clearance for iodide varies widely in normal subjects and also influences the 24-hour output of the dose, and the effects of a high thyroid clearance may be simulated by a low renal clearance. It is probably for this reason that the values from the urinary excretion test in normal and thyrotoxic subjects may overlap. This overlap could be reduced it the renal clearance were also determined, as may be done by liquid counter methods alone, but the test would then become inconveniently long, and certain other indices of differing accuracy and simplicity might be suggested. These vary in the directness with which they estimate thyroid clearance, and therefore in the crispness with which they separate normal from increased thyroid uptake of iodide. For example, a simple comparison of the counting rate opposite the neck to that opposite the thigh at one hour after the dose appears to separate the groups well and the ratio correlates closely with the thyroid clearance. As an even simpler test, the plasma radio-iodide concentration two hours after an oral or intravenous dose promises to separate the groups cleanly and it would be simple to give the dose to an outpatient, orally and several hours after food, with instructions that she return for a blood sample two hours later. The plasma could then be compared in a liquid counter with a standard containing 2 % of the dose per litre, since the normal values have been above, and those in thyrotoxicosis below, this figure. If a simple clinical test were required a number of patients could be examined in this way within an hour. For any closer analysis of the degree of thyroid overactivity in taking up iodide, the rather more complex but more direct index of thyroid clearance rate appears to be preferable, and seems likely to be of value in the analysis both of thyroid physiology and disease. THE measurement of urinary excretion of radio-active iodine is a simple procedure involving no disturbance of the patient and the minimum of apparatus. Moreover, only small doses of the isotope are required. Dr. Pochin has shown that the proportion of a dose of I131 excreted in the urine varies inversely with thyroid function, but urinary values alone will not give such an exact picture of thyroid function as the iodine clearance rate.
The present investigation was to determine whether the measurement of urinary radioiodine could be used as a routine diagnostic measure in thyroid disease. After preliminary trials a dose of 10 ,uc. of 1131 was found suitable. About 50 gamma of sodium iodide was added as carrier. The radio-activity of urine samples was measured with a glass liquid counter described by Veall, in conjunction with a conventional scaling and quenching unit, and expressed as a percentage of the dose administered.
A comparison of the twenty-four-hour excretion of I 31 in urine was made in 49 patients, in whom clinical evidence indicated normal, increased, or decreased thyroid function. 1 A fuller presentation of this subject has appeared in the Lancet (1949) ii, 456.
